This is an application for a """"""""Mentored Patient-Oriented Research Career Development Award"""""""" (K23). My career objective is to be an independent investigator advancing the treatment of schizophrenia and related psychotic disorders, emphasizing early intervention strategies. This Award will provide me the research experiences, skills, and knowledge I need to develop and test novel treatment strategies, including early intervention in patients with schizophrenia and secondary prevention for patients at the prodromal stage of psychotic disorders. The career development plan includes: 1) mentored study of Biomedical Ethics, emphasizing exploration of ethical issues in the identification and treatment of prodromal symptoms; 2) tutorials aimed to facilitate the development of an independent research application. Readings, critical discussions, and the writing of summary conceptual papers and literature will focus on phenomenology and assessment of prodromal symptoms, """"""""high risk"""""""" studies of schizophrenia, neurophysiological markers (e.g., p50 response) to identify """"""""at risk"""""""" individuals, and intervention study design in first episode and prodromal stages of psychosis that will lead to conceptual and review papers; 3) advanced courses in biostatistics and epidemiology focusing on study design and data analytic methods appropriate to longitudinal studies and clinical trials; and 4) mentored conduct of clinical trials in first-episode schizophrenia and the prodromal stage of psychosis. The prodromal stage of psychotic illness has received little systematic study, yet the findings from first-episode studies that earlier intervention may improve prognosis have resulted in the initiation of clinical programs and treatment studies directed at prodromal symptoms. The lack of a well characterized prodromal state limits these efforts, especially since identifying individuals as """"""""at risk"""""""" for a psychotic illness, and treating prodromal symptoms involve risks. The proposed research project will ascertain and prospectively follow 60 individuals with prodromal symptoms to determine risk of development of a DSM-IV psychotic illness. Refinements of the clinical criteria for prodromal state will be proposed based on the impact that specific clinical features, neurocognitive function, and family history of psychosis have on risk of development of psychosis. The study will also prospectively determine if stressful life events and substance use increase risk of progression to a psychotic disorder. The results of this study will guide the design of future intervention studies and are anticipated to provide pilot data for an R01 testing novel treatment strategies with patients in the prodromal stage of psychotic illness.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23MH001905-02
Application #
6391620
Study Section
Special Emphasis Panel (ZMH1-ITV-D (01))
Program Officer
Heinssen, Robert K
Project Start
2000-05-01
Project End
2005-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
2
Fiscal Year
2001
Total Cost
$161,922
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Psychiatry
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Velthorst, Eva; Zinberg, Jamie; Addington, Jean et al. (2018) Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Dev Psychopathol 30:39-47
Auther, A M; Cadenhead, K S; Carrión, R E et al. (2015) Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr Scand 132:60-8
Perkins, Diana O; Jeffries, Clark D; Cornblatt, Barbara A et al. (2015) Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophr Res 169:169-177
Meyer, Eric C; Carrión, Ricardo E; Cornblatt, Barbara A et al. (2014) The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr Bull 40:1452-61
Trotman, Hanan D; Holtzman, Carrie W; Walker, Elaine F et al. (2014) Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr Res 160:104-9
Tarbox, Sarah I; Addington, Jean; Cadenhead, Kristin S et al. (2014) Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Res 215:52-60
Tarbox, Sarah I; Addington, Jean; Cadenhead, Kristin S et al. (2013) Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev Psychopathol 25:1171-86
Barbato, Mariapaola; Colijn, Mark A; Keefe, Richard S E et al. (2013) The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. Psychiatry Res 206:195-9
Piskulic, Danijela; Addington, Jean; Cadenhead, Kristin S et al. (2012) Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res 196:220-4
Addington, Jean; Cornblatt, Barbara A; Cadenhead, Kristin S et al. (2011) At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 168:800-5

Showing the most recent 10 out of 24 publications